Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00409643
Status:
COMPLETED
Last Update Posted:
2011-11-08
First Post:
2006-12-07
Brief Title:
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Randomized Double-blind Multicenter Multifactorial Placebo-controlled Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan 160 mg and 320 mg and Amlodipine 10 mg Combined and Alone in Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial will compare valsartan and amlodipine combination therapies to valsartan and amlodipine monotherapyand placebo for treating patients with hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None